NECTIN4 and cancer: EV is taken up by the body after binding to Nectin-4, which is a Ca2+-independent immunoglobulin-like protein that is highly expressed on the surface of cancer cells; subsequently, MMAE is released into the cells to inhibit cell division, induce apoptosis, and exert its anti-tumor effect [12,13].